Vích Z
Health Institute of Uranium Industry, Príbram, Czechoslovakia.
Neoplasma. 1988;35(2):129-33.
Using the Kaplan-Meier method, actuarial survival data were estimated in cancer patients registered in the Cancer Registry of Health Institute of Uranium Industry during 1976-1983, and in those followed up for 3 years and longer after the initiation of their treatment. Due to the specificity of this registry, a more detailed analysis was feasible in 639 lung cancer men. The estimated probabilities of survival over 5 and 10 years respectively, were: In all lung cancers 0.10 and 0.08, in all Stage I and II lung cancers 0.24 and 0.20, of them in epidermoid carcinomas 0.31 and 0.25, in radically operated tumors 0.51 and 0.43, of them in epidermoid carcinomas 0.54 and 0.45 respectively. The results confirmed the principal importance of early diagnosis of bronchogenic cancer, especially of epidermoid carcinoma, at a resectable stage.
采用Kaplan-Meier法，对1976年至1983年期间铀工业卫生研究所癌症登记处登记的癌症患者，以及治疗开始后随访3年及以上的患者进行了精算生存数据估计。由于该登记处的特殊性，对639名男性肺癌患者进行了更详细的分析。5年和10年的估计生存概率分别为：在所有肺癌中为0.10和0.08，在所有I期和II期肺癌中为0.24和0.20，其中在鳞状细胞癌中为0.31和0.25，在根治性手术的肿瘤中为0.51和0.43，其中在鳞状细胞癌中分别为0.54和0.45。结果证实了在可切除阶段早期诊断支气管癌，尤其是鳞状细胞癌的重要性。
